India’s drug regulator warns on Abbott’s bioresorbable stentsPost published:August 9, 2017Post category:Industry NewsThe Drug Controller General of India’s (DCGI) warning pertains to bioresorbable stents used in blood vessels that are 2.5mm or narrower Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDilip Shanghvi’s oil firm may buy GSPC’s Hazira field Next PostBoeing eyes India tie-ups for drones, digital technology You Might Also Like AW-Lake Company introduces HUB-40EX flow sensor May 21, 2019 IGEL releases info brief on developoing Linux OS-based devices at the edge June 27, 2019 Financial investors joining hands with utilities to acquire power projects March 19, 2017